Literature DB >> 30255221

Mutations of ARX and non-syndromic intellectual disability in Chinese population.

Yufei Wu1, Huan Zhang2, Xiaofen Liu1, Zhangyan Shi1, Hongling Li1, Zhibin Wang1, Xiaoyong Jie3, Shaoping Huang2, Fuchang Zhang1,4, Junlin Li1, Kejin Zhang5, Xiaocai Gao6,7.   

Abstract

Mutations of Aristaless-related homeobox (ARX) gene were looked as the third cause of non-syndromic intellectual disability (NSID), while the boundary between true disease-causing mutations and non-disease-causing variants within this gene remains elusive. To investigate the relationship between ARX mutations and NSID, a panel comprising six reported causal mutations of the ARX was detected in 369 sporadic NSID patients and 550 random participants in Chinese. Two mutations, c.428_451 dup and p.G286S, may be disease-causing mutations for NSID, while p.Q163R and p.P353L showed a great predictive value in female NSID diagnosis with significant associations (X2 = 19.60, p = 9.54e-6 for p.Q163R; X2 = 25.70, p = 4.00e-07 for p.P353L), carriers of these mutations had an increased risk of NSID of more than fourfold. Detection of this panel also predicted significant associations between genetic variants of the ARX gene and NSID (p = 3.73e-4). The present study emphasized the higher genetic burden of the ARX gene on NSID in the Chinese population, molecular analysis of this gene should be considered for patients presenting NSID of unknown etiology.

Entities:  

Keywords:  Aristaless-related homeobox (ARX); Disease-causing mutation; Genetic counseling; Non-syndromic intellectual disability

Mesh:

Substances:

Year:  2018        PMID: 30255221     DOI: 10.1007/s13258-018-0745-6

Source DB:  PubMed          Journal:  Genes Genomics        ISSN: 1976-9571            Impact factor:   1.839


  33 in total

1.  Statistical tests for detecting rare variants using variance-stabilising transformations.

Authors:  Kai Wang; John H Fingert
Journal:  Ann Hum Genet       Date:  2012-06-25       Impact factor: 1.670

2.  Screening of ARX in mental retardation families: Consequences for the strategy of molecular diagnosis.

Authors:  K Poirier; D Lacombe; B Gilbert-Dussardier; M Raynaud; V Desportes; A P M de Brouwer; C Moraine; J P Fryns; H H Ropers; C Beldjord; J Chelly; T Bienvenu
Journal:  Neurogenetics       Date:  2005-10-19       Impact factor: 2.660

Review 3.  X-linked mental retardation: vanishing boundaries between non-specific (MRX) and syndromic (MRXS) forms.

Authors:  S G M Frints; G Froyen; P Marynen; J-P Fryns
Journal:  Clin Genet       Date:  2002-12       Impact factor: 4.438

4.  X linked mental retardation and infantile spasms in a family: new clinical data and linkage to Xp11.4-Xp22.11.

Authors:  P Strømme; K Sundet; C Mørk; J J Cassiman; J P Fryns; S Claes
Journal:  J Med Genet       Date:  1999-05       Impact factor: 6.318

Review 5.  The ARX story (epilepsy, mental retardation, autism, and cerebral malformations): one gene leads to many phenotypes.

Authors:  Elliott H Sherr
Journal:  Curr Opin Pediatr       Date:  2003-12       Impact factor: 2.856

6.  Prevalence, treatment, and associated disability of mental disorders in four provinces in China during 2001-05: an epidemiological survey.

Authors:  Michael R Phillips; Jingxuan Zhang; Qichang Shi; Zhiqiang Song; Zhijie Ding; Shutao Pang; Xianyun Li; Yali Zhang; Zhiqing Wang
Journal:  Lancet       Date:  2009-06-13       Impact factor: 79.321

7.  Identification of Arx transcriptional targets in the developing basal forebrain.

Authors:  Carl T Fulp; Ginam Cho; Eric D Marsh; Ilya M Nasrallah; Patricia A Labosky; Jeffrey A Golden
Journal:  Hum Mol Genet       Date:  2008-09-16       Impact factor: 6.150

8.  A polyalanine tract expansion in Arx forms intranuclear inclusions and results in increased cell death.

Authors:  Ilya M Nasrallah; Jeremy C Minarcik; Jeffrey A Golden
Journal:  J Cell Biol       Date:  2004-11-08       Impact factor: 10.539

9.  Unraveling the pathogenesis of ARX polyalanine tract variants using a clinical and molecular interfacing approach.

Authors:  Isabel Marques; Maria João Sá; Gabriela Soares; Maria do Céu Mota; Carla Pinheiro; Lisa Aguiar; Marta Amado; Christina Soares; Angelina Calado; Patrícia Dias; Ana Berta Sousa; Ana Maria Fortuna; Rosário Santos; Katherine B Howell; Monique M Ryan; Richard J Leventer; Rani Sachdev; Rachael Catford; Kathryn Friend; Tessa R Mattiske; Cheryl Shoubridge; Paula Jorge
Journal:  Mol Genet Genomic Med       Date:  2015-02-25       Impact factor: 2.183

10.  Exome sequencing covers >98% of mutations identified on targeted next generation sequencing panels.

Authors:  Holly LaDuca; Kelly D Farwell; Huy Vuong; Hsiao-Mei Lu; Wenbo Mu; Layla Shahmirzadi; Sha Tang; Jefferey Chen; Shruti Bhide; Elizabeth C Chao
Journal:  PLoS One       Date:  2017-02-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.